REPORTS

Let’s Pullulate and Expand Your Business

Hormonal Contraceptives Market - Global Professional Analysis and Forecast to 2026

Oct 16, 2019  |  162 PAGES  |  REPORT CODE: CMM213536
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Hormonal Contraceptives market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.5% during the forecast period.

This report presents the market size and development trends by detailing the Hormonal Contraceptives market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Hormonal Contraceptives market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Hormonal Contraceptives industry and will help you to build a panoramic view of the industrial development.

Hormonal Contraceptives Market, By Type:

  • Pill

  • Intrauterine Device (IUD)

  • Injectable

  • Others

Hormonal Contraceptives Market, By Application:

  • Hospitals

  • Homecare

  • Gynecology Centers

Some of the leading players are as follows:

  • V-Care Pharma

  • Lupin Pharmaceuticals

  • HLL Lifecare

  • Pfizer

  • Janssen Pharmaceuticals

  • Caya

  • Teva Pharmaceuticals

  • Syzygy Healthcare

  • Agile Therapeutics

  • Lipocine

  • Allergan

  • Mayer Laboratories

  • Ansell

  • Afaxys

  • Bayer Pharma

  • Okamoto Industries

  • Fuji Latex

  • Merck Millipore

  • Female Health

  • Reckitt Benckiser

  • Ferring Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Hormonal Contraceptives Market: Technology Type Analysis

  • 4.1 Hormonal Contraceptives Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Hormonal Contraceptives Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pill

    • 4.3.2 Intrauterine Device (IUD)

    • 4.3.3 Injectable

    • 4.3.4 Others

5 Hormonal Contraceptives Market: Product Analysis

  • 5.1 Hormonal Contraceptives Product Market Share Analysis, 2018 & 2026

  • 5.2 Hormonal Contraceptives Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Hormonal Contraceptives Market: Application Analysis

  • 6.1 Hormonal Contraceptives Application Market Share Analysis, 2018 & 2026

  • 6.2 Hormonal Contraceptives Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Homecare

    • 6.3.3 Gynecology Centers

7 Hormonal Contraceptives Market: Regional Analysis

  • 7.1 Hormonal Contraceptives Regional Market Share Analysis, 2018 & 2026

  • 7.2 Hormonal Contraceptives Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 V-Care Pharma

    • 9.1.1 V-Care Pharma Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Lupin Pharmaceuticals

    • 9.2.1 Lupin Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 HLL Lifecare

    • 9.3.1 HLL Lifecare Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pfizer

    • 9.4.1 Pfizer Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Janssen Pharmaceuticals

    • 9.5.1 Janssen Pharmaceuticals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Caya

    • 9.6.1 Caya Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Teva Pharmaceuticals

    • 9.7.1 Teva Pharmaceuticals Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Syzygy Healthcare

    • 9.8.1 Syzygy Healthcare Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Agile Therapeutics

    • 9.9.1 Agile Therapeutics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Lipocine

    • 9.10.1 Lipocine Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Allergan

    • 9.11.1 Allergan Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Mayer Laboratories

    • 9.12.1 Mayer Laboratories Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Ansell

    • 9.13.1 Ansell Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Afaxys

    • 9.14.1 Afaxys Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Bayer Pharma

    • 9.15.1 Bayer Pharma Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Okamoto Industries

    • 9.16.1 Okamoto Industries Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Fuji Latex

    • 9.17.1 Fuji Latex Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Merck Millipore

    • 9.18.1 Merck Millipore Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Female Health

    • 9.19.1 Female Health Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Reckitt Benckiser

    • 9.20.1 Reckitt Benckiser Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Ferring Pharmaceuticals

    • 9.21.1 Ferring Pharmaceuticals Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

 

The List of Tables and Figures (Totals 104 Figures and 161 Tables)

  • Figure Pill Hormonal Contraceptives market, 2015 - 2026 (USD Million)

  • Figure Intrauterine Device (IUD) Hormonal Contraceptives market, 2015 - 2026 (USD Million)

  • Figure Injectable Hormonal Contraceptives market, 2015 - 2026 (USD Million)

  • Figure Others Hormonal Contraceptives market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Homecare market, 2015 - 2026 (USD Million)

  • Figure Gynecology Centers market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Hormonal Contraceptives market, by country, 2015 - 2026 (USD Million)

  • Table North America Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table North America Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table North America Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Canada Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Canada Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Europe Hormonal Contraceptives market, by country, 2015 - 2026 (USD Million)

  • Table Europe Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Europe Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Europe Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Germany Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Germany Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table France Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table France Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Italy Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Italy Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Spain Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Spain Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hormonal Contraceptives market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table China Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table China Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Japan Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Japan Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table India Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table India Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Hormonal Contraceptives market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table MEA Hormonal Contraceptives market, by country, 2015 - 2026 (USD Million)

  • Table MEA Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table MEA Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table MEA Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Hormonal Contraceptives market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Hormonal Contraceptives market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Hormonal Contraceptives market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table V-Care Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lupin Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table HLL Lifecare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Caya Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Syzygy Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agile Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lipocine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mayer Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ansell Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Afaxys Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Okamoto Industries Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fuji Latex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Millipore Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Female Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Reckitt Benckiser Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ferring Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top